User profiles for A Saei

Ahmet SARI

- Verified email at ktu.edu.tr - Cited by 32132

Ayoub Saei

- Verified email at ukhsa.gov.uk - Cited by 3231

Amir Ata Saei

- Verified email at ki.se - Cited by 3226

Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges

S Laurent, AA Saei, S Behzadi… - Expert opinion on …, 2014 - Taylor & Francis
Introduction: Bearing in mind that many promising drug candidates have the problem of
reaching their target site, the concept of advanced drug delivery can play a significant …

Electrochemical biosensors for glucose based on metal nanoparticles

AA Saei, JEN Dolatabadi, P Najafi-Marandi… - TrAC Trends in …, 2013 - Elsevier
Nanotechnology has affected almost all aspects of biomedicine. The integration of
nanomaterials has contributed to the selectivity, the versatility, the stability and especially the …

Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges

Z Bakhtiary, AA Saei, MJ Hajipour, M Raoufi… - … , Biology and Medicine, 2016 - Elsevier
Nanomedicine, the integration of nanotechnological tools in medicine demonstrated promising
potential to revolutionize the diagnosis and treatment of various human health conditions. …

[HTML][HTML] Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection

…, S Foulkes, F Insalata, P Kirwan, A Saei… - … England Journal of …, 2022 - Mass Medical Soc
Background The duration and effectiveness of immunity from infection with and vaccination
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relevant to …

[PDF][PDF] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

…, E Phillips, T Malone, A Hargreaves, A Shields, A Saei… - Cell, 2021 - cell.com
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …

[HTML][HTML] SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort …

…, EJM Monk, R Simmons, E Wellington, MJ Cole, A Saei… - The Lancet, 2021 - thelancet.com
Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to …

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre …

VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti… - The Lancet, 2021 - thelancet.com
Background BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have
been rapidly rolled out in the UK from December, 2020. We aimed to determine the factors …

Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort …

…, EJM Monk, R Simmons, E Wellington, MJ Cole, A Saei… - Medrxiv, 2021 - medrxiv.org
Background There is an urgent need to better understand whether individuals who have
recovered from COVID-19 are protected from future SARS-CoV-2 infection. Methods A large …

[HTML][HTML] Effectiveness of BNT162b2 mRNA vaccine against infection and COVID-19 vaccine coverage in healthcare workers in England, multicentre prospective …

VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti… - 2021 - papers.ssrn.com
Background: BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have
been rapidly rolled out in the UK. We determined the factors associated with vaccine coverage …

Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon …

M Azhdarzadeh, F Atyabi, AA Saei… - Colloids and Surfaces B …, 2016 - Elsevier
Favorable physiochemical properties and the capability to accommodate targeting moieties
make superparamegnetic iron oxide nanoparticles (SPIONs) popular theranostic agents. In …